Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 87283 refers to a laboratory test specifically designed for the detection of the rubeola virus antigen using an immunofluorescent technique. This test is crucial for identifying the presence of the rubeola virus, which is responsible for measles, a highly contagious viral infection characterized by respiratory symptoms and a distinctive rash. The rubeola virus is a single-stranded, enveloped RNA virus with only one serotype, making it unique in its classification. The procedure involves collecting samples from the patient, which may include nasal or pharyngeal swabs, aspirates, urine, or serum. The immunofluorescent technique employed in this test utilizes specific antibodies that bind to the rubeola virus antigens present in the sample. When these antibodies are applied to the sample and examined under an epifluorescence microscope, any binding will result in a visible color change, indicating the presence of the virus. This method is noted for its rapid results, although it may be less sensitive compared to other testing methods such as reverse transcription-polymerase chain reaction (RT-PCR). Understanding the implications of this test is essential for timely diagnosis and management of measles, especially considering the contagious nature of the virus and the potential for outbreaks in unvaccinated populations.
© Copyright 2026 Coding Ahead. All rights reserved.
The CPT® Code 87283 is indicated for the detection of the rubeola virus antigen in patients who present with symptoms consistent with measles. The following conditions warrant the performance of this test:
The procedure for performing the test under CPT® Code 87283 involves several critical steps to ensure accurate detection of the rubeola virus antigen:
After the procedure, the results of the test will be analyzed and reported. It is important to note that while the immunofluorescent technique provides rapid results, it may be less sensitive than other methods such as reverse transcription-polymerase chain reaction (RT-PCR). Therefore, if the test result is negative but clinical suspicion remains high, further testing may be warranted. Additionally, healthcare providers should consider the patient's clinical history and symptoms when interpreting the results. Proper follow-up care and monitoring for any potential complications associated with measles should be conducted, especially in cases where the patient is confirmed to have the virus.
| Short Descr | RUBEOLA AG IF | Medium Descr | IAADI RUBEOLA | Long Descr | Infectious agent antigen detection by immunofluorescent technique; Rubeola | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Changed | Short description changed. |
| 2001-01-01 | Added | First appearance in code book in 2001. |
Get instant expert-level medical coding assistance.